WHO GUIDELINE ON MASS DRUG ADMINISTRATION OF AZITHROMYCIN TO CHILDREN UNDER FIVE YEARS OF AGE TO PROMOTE CHILD SURVIVAL

Guideline purpose and scope: The purpose of the guideline was to provide an evidence-informed recommendation on whether mass drug administration of azithromycin, as a public health intervention for the reduction of under-five mortality, should (a) be rolled out universally in low-and middle-income countries, (b) be applied only in some situational contexts in low- and middle-income countries or (c) not be used at all.